Asset Details
Do you wish to reserve the book?
Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma
Do you wish to request the book?
Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Survivin, a molecular target for therapeutic interventions in squamous cell carcinoma
2017
Overview
Squamous cell carcinoma (SCC) is the most common cancer worldwide. The treatment of locally advanced disease generally requires various combinations of radiotherapy, surgery, and systemic therapy. Despite aggressive multimodal treatment, most of the patients relapse. Identification of molecules that sustain cancer cell growth and survival has made molecular targeting a feasible therapeutic strategy. Survivin is a member of the Inhibitor of Apoptosis Protein (IAP) family, which is overexpressed in most of the malignancies including SCC and totally absent in most of the normal tissues. This feature makes survivin an ideal target for cancer therapy. It orchestrates several important mechanisms to support cancer cell survival including inhibition of apoptosis and regulation of cell division. Overexpression of survivin in tumors is also associated with poor prognosis, aggressive tumor behavior, resistance to therapy, and high tumor recurrence. Various strategies have been developed to target survivin expression in cancer cells, and their effects on apoptosis induction and tumor growth attenuation have been demonstrated. In this review, we discuss recent advances in therapeutic potential of survivin in cancer treatment.
Publisher
BioMed Central,Springer Nature B.V,BMC
Subject
Antineoplastic Agents - pharmacology
/ Biological and Medical Physics
/ Biomedical and Life Sciences
/ Carcinoma, Squamous Cell - drug therapy
/ Carcinoma, Squamous Cell - metabolism
/ Carcinoma, Squamous Cell - physiopathology
/ Genes
/ Humans
/ Inhibitor of Apoptosis Proteins - drug effects
/ Proteins
/ Review
/ Squamous cell carcinoma (SCC)
/ Survivin
/ Tumors
/ YM155
